[Neurotensin in Itsenko-Cushing disease].

Area of Science:

• Endocrinology
• Neuroscience

Background:

• Icenko-Cushing's disease involves adrenal dysfunction.
• Neurotensin's role in this condition requires further investigation.

Purpose of the Study:

• To investigate blood neurotensin concentrations in patients with Icenko-Cushing's disease.
• To assess neurotensin response to various stimuli and treatments.

Main Methods:

• Radioimmunoassay was used to measure fasting blood neurotensin.
• Measurements were taken after insulin, glucose, peritol, and parlodel administration.
• Neurotensin levels were monitored during treatment with chloditane and combined therapies.

Main Results:

• Elevated blood neurotensin was observed in active Icenko-Cushing's disease.
• No significant changes in neurotensin occurred in healthy subjects or patients under induced stress.
• Treatment with chloditane normalized neurotensin levels, while combined therapy with a dopaminergic drug did not.

Conclusions:

• Blood neurotensin concentration is a potential biomarker for active Icenko-Cushing's disease.
• Treatment strategies impact neurotensin normalization.
• Further research into neurotensin's specific role is warranted.